U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Cellular & Gene Therapy Products
  4. LENMELDY
  1. Cellular & Gene Therapy Products

STN: 125758
Proper Name: atidarsagene autotemcel
Trade Name: LENMELDY
Manufacture: Orchard Therapeutics (Europe) Limited
Indication: 

  • Indicated for the treatment of children with pre-symptomatic late infantile (PSLI), pre-symptomatic early juvenile (PSEJ) or early symptomatic early juvenile (ESEJ) metachromatic leukodystrophy (MLD)

Product Information

Support Documents

Back to Top